The Life Sciences Practice assists biotechnology and pharmaceuticals enterprises in developing funding strategies to capitalize their businesses and the commercialization process. Life Sciences attorneys work closely with Spencer Fane's Business Transactions Practice, which serves clients ranging in size from small start-up entities to very large public companies. Our attorneys counsel and advise clients regarding mergers and acquisitions, debt and equity financing, securities, corporate governance, executive employment agreements, regulatory matters, partnerships and joint ventures, and taxation. Our experience also includes conducting intellectual property due diligence as a part of initial public offerings (IPOs), private placements, mergers, acquisitions, and spin-outs.

We also represent lenders, borrowers, investors, and life sciences growth companies in structuring, negotiating, and closing a wide variety of financing and capital formation transactions, including senior term and revolving credit facilities, subordinated debt, convertible debt, venture and private equity financing, and restructurings. Our experience includes working directly with investors in preparing:

• Legal opinions including patentability, infringement, validity, and freedom-to-operate opinions
• Patent portfolio audits
• Patent landscape analyses
• Technology clearance studies

The Life Sciences Practice has also assisted its clients in identifying potential sources of capital, market conditions, and in determining what technologies may be over- or under-invested, and in developing venture management strategies. By doing so, the information our clients obtain from angel, corporate, and venture investors can be leveraged to more effectively develop intellectual property strategies that protect technologies better predicted to be "investable." No matter what your financial position may be, Spencer Fane attorneys are able to assist in capitalizing the research and development of life sciences technologies.